AmCham Indonesia held its second Pharmaceutical and Medical Devices Committee Meeting of the year on July 30, bringing together members to discuss key regulatory and policy developments shaping Indonesia’s healthcare landscape.
The session featured valuable remarks and insights from Committee Chairs Ika Noviera from GE HealthCare and Aulia Citta Arieni from PT Anugerah Pharmindo Lestari (APL). The meeting also provided an opportunity to review the Committee’s ongoing advocacy initiatives and assess progress on key priority areas. Participants shared updates on advocacy efforts related to halal requirements for medical devices and the broader healthcare sector, import approvals for pharmaceutical-grade salt and sugar, and over-the-counter (OTC) product distribution. The discussion also covered recent regulatory developments concerning health supplies, health technology assessment, and non-halal labelling.
Members exchanged perspectives on further advocacy actions for the second half of the year, highlighting the Committee’s key priorities and the importance of continued engagement between the private sector and government stakeholders. These efforts aim to address regulatory challenges and support a more effective and responsive healthcare policy environment.
AmCham extends its appreciation to all participants for their valuable contributions. We remain committed to fostering constructive dialogue and collaboration in support of Indonesia’s evolving healthcare landscape.
For opportunity for additional visibility please contact: [email protected]
_6a6c4495add6c.png)
_6a6c4498cbcfa.png)
_6a6c44a1a76b1.png)
_6a6c44ac809c0.png)
_6a6c44af40083.png)
_6a6c44b22ea7c.png)
_6a6c4495add6c.png)
_6a6c4498cbcfa.png)
_6a6c44a1a76b1.png)
_6a6c44ac809c0.png)
_6a6c44af40083.png)
_6a6c44b22ea7c.png)
